West Pharmaceutical Services (WST) Revenue (2009 - 2026)

West Pharmaceutical Services' Revenue history runs 18 years deep, the most recent figure standing at $844.9 million for Q1 2026.

• In Q1 2026, Revenue rose 21.05% year-over-year to $844.9 million; the TTM figure through Mar 2026 stood at $3.2 billion (up 11.23% YoY), while the FY2025 annual figure was $3.1 billion, up 6.25% from the prior year.
• Revenue came in at $844.9 million for Q1 2026 at West Pharmaceutical Services, up from $805.0 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $844.9 million in Q1 2026 to a low of $686.9 million in Q3 2022.
• A 5-year average of $744.1 million and a median of $746.9 million in 2024 frame the typical range for Revenue.
• Across the five-year window, Revenue slipped 6.86% in 2024 and rose 21.05% in 2026, its largest moves.
• West Pharmaceutical Services' Revenue stood at $708.7 million in 2022, then grew by 3.29% to $732.0 million in 2023, then gained by 2.3% to $748.8 million in 2024, then rose by 7.51% to $805.0 million in 2025, then grew by 4.96% to $844.9 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $844.9 million, $805.0 million, and $804.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison